Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Liabilities and Shareholders Equity (2018 - 2026)

Profound Medical has reported Liabilities and Shareholders Equity over the past 8 years, most recently at $77.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 10.31% year-over-year to $77.5 million; the TTM value through Dec 2025 reached $230.3 million, up 5.23%, while the annual FY2025 figure was $77.5 million, 10.31% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $77.5 million at Profound Medical, up from $42.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $95.8 million in Q2 2021 and troughed at $61242.0 in Q1 2023.
  • A 5-year average of $56.7 million and a median of $57.0 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 94603565.31% in 2021 and later plummeted 31.77% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $86.8 million in 2021, then decreased by 25.76% to $64.4 million in 2022, then plummeted by 31.77% to $44.0 million in 2023, then soared by 59.78% to $70.2 million in 2024, then increased by 10.31% to $77.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PROF at $77.5 million in Q4 2025, $42.3 million in Q3 2025, and $49.7 million in Q2 2025.